Northern Trust’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-371,944
| Closed | -$826K | – | 4642 |
|
2021
Q1 | $826K | Sell |
371,944
-28,913
| -7% | -$64.2K | ﹤0.01% | 3658 |
|
2020
Q4 | $994K | Buy |
400,857
+1,705
| +0.4% | +$4.23K | ﹤0.01% | 3523 |
|
2020
Q3 | $982K | Sell |
399,152
-8,780
| -2% | -$21.6K | ﹤0.01% | 3403 |
|
2020
Q2 | $1.45M | Buy |
+407,932
| New | +$1.45M | ﹤0.01% | 3202 |
|
2019
Q3 | – | Sell |
-262,351
| Closed | -$381K | – | 4307 |
|
2019
Q2 | $381K | Sell |
262,351
-20,431
| -7% | -$29.7K | ﹤0.01% | 3632 |
|
2019
Q1 | $557K | Buy |
282,782
+5,225
| +2% | +$10.3K | ﹤0.01% | 3520 |
|
2018
Q4 | $363K | Buy |
277,557
+6,026
| +2% | +$7.88K | ﹤0.01% | 3628 |
|
2018
Q3 | $668K | Sell |
271,531
-1,294
| -0.5% | -$3.18K | ﹤0.01% | 3575 |
|
2018
Q2 | $916K | Buy |
272,825
+21,828
| +9% | +$73.3K | ﹤0.01% | 3475 |
|
2018
Q1 | $1.06M | Buy |
250,997
+5,177
| +2% | +$21.9K | ﹤0.01% | 3362 |
|
2017
Q4 | $812K | Sell |
245,820
-5,790
| -2% | -$19.1K | ﹤0.01% | 3456 |
|
2017
Q3 | $962K | Buy |
251,610
+206,309
| +455% | +$789K | ﹤0.01% | 3445 |
|
2017
Q2 | $199K | Buy |
+45,301
| New | +$199K | ﹤0.01% | 3800 |
|
2014
Q3 | – | Sell |
-27,050
| Closed | -$134K | – | 4368 |
|
2014
Q2 | $134K | Buy |
+27,050
| New | +$134K | ﹤0.01% | 3955 |
|